The kidney reabsorption-related magnesium depletion score is associated with cardiovascular disease and longitudinal mortality in diabetic kidney disease patients

被引:1
|
作者
Zhou, Zhengxi [1 ]
Yao, Xiaotian [1 ,2 ,3 ]
机构
[1] Ningbo Mingzhou Hosp, Dept Urol, Ningbo, Zhejiang, Peoples R China
[2] Sun Yat sen Univ, Affiliated Hosp 6, Div Nephrol, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat sen Univ, Affiliated Hosp 6, Biomed Innovat Ctr, Guangzhou, Guangdong, Peoples R China
关键词
MDS; Magnesium depletion score; DKD; Mortality; CVD; SERUM MAGNESIUM; HYPOMAGNESEMIA; REQUIREMENTS; PREVENTION; EXCRETION; UPDATE;
D O I
10.1186/s13098-025-01598-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The kidney reabsorption is essential for maintaining magnesium homeostasis. This study aims to explore the relationship between kidney reabsorption-related magnesium depletion score (MDS) and the occurrence of cardiovascular disease (CVD) and prognosis in diabetic disease kidney (DKD) patients. Methods We included 3199 DKD patients from the National Health and Nutrition Examination Survey (NHANES) database, including 1072 CVD patients. Weighted logistic regression analysis was used to explore the relationship between MDS and the occurrence of CVD. Weighted COX proportional hazards regression was used to explore the relationship between MDS and mortality. Stratified analysis was used to further validate. Finally, we assessed the predictive accuracy of MDS on survival outcomes in DKD patients using time-dependent receiver operating characteristic (ROC) curve analysis. Results Survey-weighted multiple logistic regression analysis revealed that MDS >= 3, the incidence of CVD increased by 371%. During the follow-up period (median of 87 months), 1373 all-cause deaths (497 cardiovascular deaths) were recorded. In DKD patients, MDS >= 3, all-cause mortality increased 78% (P < 0.001) and cardiac mortality 76% (P = 0.08). Consistent results were also shown when stratified by age, sex, race, marital status, magnesium intake. The area under the curve (AUC) values for predicting 1-,2-,3-,4-, and 5-year mortality using MDS were 0.86, 0.66, 0.59, 0.57, and 0.55, for all-cause mortality and 0.9, 0.67, 0.62, 0.58, and 0.56 for cardiovascular mortality. Conclusion MDS, kidney reabsorption-related, is positively correlated with the incidence of CVD and longitudinal mortality in DKD patients.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease
    Bleyer, Anthony J.
    Sedor, John R.
    Freedman, Barry I.
    O'Brien, Alicia
    Russell, Gregory B.
    Graley, Joni
    Schelling, Jeffrey R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (01) : 29 - 37
  • [42] Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients
    Zoppini, Giacomo
    Targher, Giovanni
    Chonchol, Michel
    Negri, Carlo
    Stoico, Vincenzo
    Pichiri, Isabella
    Lippi, Giuseppe
    Muggeo, Michele
    Bonora, Enzo
    ATHEROSCLEROSIS, 2010, 210 (02) : 575 - 580
  • [43] SCREENING FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE
    Sharma, Rajan
    JOURNAL OF RENAL CARE, 2010, 36 : 68 - 75
  • [44] Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease
    Sapa, Hima
    Gutierrez, Orlando M.
    Shlipak, Michael G.
    Katz, Ronit
    Ix, Joachim H.
    Sarnak, Mark J.
    Cushman, Mary
    Rhee, Eugene P.
    Kimmel, Paul L.
    Vasan, Ramachandran S.
    Schrauben, Sarah J.
    Feldman, Harold I.
    Seegmiller, Jesse C.
    Brunengraber, Henri
    Hostetter, Thomas H.
    Schelling, Jeffrey R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 80 (04) : 502 - +
  • [45] Heparin and related substances for preventing diabetic kidney disease
    Li, Jun
    Wu, Hong Mei
    Zhang, Ling
    Zhu, Bin
    Dong, Bi Rong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (09):
  • [46] Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease
    Nordholm, Anders
    Sorensen, Ida M. H.
    Bjergfelt, Sasha S.
    Fuchs, Andreas
    Kofoed, Klaus F.
    Landler, Nino E.
    Biering-Sorensen, Tor
    Carlson, Nicholas
    Feldt-Rasmussen, Bo
    Christoffersen, Christina
    Bro, Susanne
    CLINICAL KIDNEY JOURNAL, 2023, 16 (12) : 2712 - 2720
  • [47] Association of haemoglobin glycation index with all-cause and cardiovascular disease mortality in diabetic kidney disease: a cohort study
    Huang, Lihua
    He, Liuliu
    Luo, Xiaoyan
    Zhou, Xiaoqing
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01)
  • [48] High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients
    Liabeuf, Sophie
    Barreto, Daniela V.
    Kretschmer, Axel
    Barreto, Fellype C.
    Renard, Cedric
    Andrejak, Michel
    Choukroun, Gabriel
    Massy, Ziad
    ATHEROSCLEROSIS, 2011, 215 (01) : 116 - 124
  • [49] Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease
    Balafa, Olga
    Fernandez-Fernandez, Beatriz
    Ortiz, Alberto
    Dounousi, Evangelia
    Ekart, Robert
    Ferro, Charles J.
    Mark, Patrick B.
    Valdivielso, Jose M.
    Del Vecchio, Lucia
    Mallamaci, Francesca
    CLINICAL KIDNEY JOURNAL, 2024, 17 (03)
  • [50] Associated factors related to chronic kidney disease progression in elderly patients
    Totoli, Claudia
    Carvalho, Aluizio Barbosa
    Ammirati, Adriano Luiz
    Draibe, Sergio Antonio
    Canziani, Maria Eugenia F.
    PLOS ONE, 2019, 14 (07):